Simonian Nancy A

CIK 00013595746 companiesSOMERVILLE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001359574

Recent Transactions

50 trades

Award
Generate Biomedicines, Inc.$GENB
Stock Option (Right to Buy)
2026-02-26+29,561→ 29,561 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-12-02$0.27/sh−37,070→ 4,000 total
Sale
Syros Pharmaceuticals, Inc.
Common Stock
2024-11-25$0.27/sh−134,713→ 41,070 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-10-31−40,125→ 0 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-10-31+40,125→ 175,783 total
Award
Syros Pharmaceuticals, Inc.
Common Stock
2024-06-05+4,000→ 135,658 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2024-06-05+6,000→ 6,000 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2024-04-01$5.12/sh−14,052→ 131,658 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−39,566→ 79,134 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+39,566→ 145,710 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2024-03-31+6,000→ 106,144 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2024-03-31−6,000→ 12,000 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Restricted Stock Units
2023-12-14−2,044→ 0 total
Disposition to Issuer
Seagen Inc.
Common Stock
2023-12-14$229.00/sh−62,753→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,676→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−7,038→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,462→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−8,750→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−9,260→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,171→ 0 total
Disposition to Issuer
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-12-01−17,499→ 0 total
Disposition to Issuer
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-12-01−28,001→ 0 total
Disposition to Issuer
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-12-01−7,500→ 0 total
Disposition to Issuer
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-12-01−30,399→ 0 total
Disposition to Issuer
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-12-01−29,399→ 0 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-11-01$2.22/sh−13,401→ 100,144 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-10-31+40,125→ 113,545 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-10-31−40,125→ 40,125 total
Award
Seagen Inc.
Common Stock
2023-05-31+2,044→ 64,797 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2023-04-03$2.58/sh−1,852→ 73,420 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-03-31−6,000→ 18,000 total
Exercise/Conversion
Syros Pharmaceuticals, Inc.
Common Stock
2023-03-31+6,000→ 75,272 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2023-02-16+118,700→ 118,700 total
Exercise/Conversion
Seagen Inc.
Common Stock
2022-12-12$36.70/sh+8,750→ 62,753 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-12-12−8,750→ 0 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-10-06+80,250→ 80,250 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-10-06+115,000→ 115,000 total
Award
Seagen Inc.
Common Stock
2022-05-13+1,503→ 54,003 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-05-13+3,676→ 3,676 total
Tax Payment
Syros Pharmaceuticals, Inc.
Common Stock
2022-04-01$1.12/sh−58,883→ 692,723 total
Exercise/Conversion
Seagen Inc.
Common Stock
2022-03-02$20.04/sh+25,000→ 52,500 total
Exercise/Conversion
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2022-03-02−25,000→ 0 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+400,000→ 400,000 total
Award
Syros Pharmaceuticals, Inc.
Restricted Stock Units
2022-02-15+240,000→ 240,000 total
Award
Syros Pharmaceuticals, Inc.
Stock Option (right to buy)
2022-02-15+375,000→ 375,000 total
Award
Seagen Inc.
Common Stock
2021-05-14+1,402→ 27,500 total
Award
Seagen Inc.
Non-Qualified Stock Option (right to buy)
2021-05-14+3,462→ 3,462 total

Companies

Recent Filings

Address

GENERATE BIOMEDICINES, INC. 101 SOUTH STREET, SUITE 900

SOMERVILLE, MA, 02143

View on SEC.gov